| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neurexin family protein binding | 1.02e-08 | 16 | 97 | 5 | GO:0042043 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | FLNB NLGN4Y SPTBN2 NLGN1 ADAM22 PTPRT NLGN3 NLGN4X BAIAP2L1 TJP1 NLGN2 | 1.55e-04 | 599 | 97 | 11 | GO:0050839 |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 NCALD DSC3 DSPP PLA2G4D PLA2G4E PKDREJ LRP1B HMCN1 FKBP7 MMP13 ATP2A2 | 2.73e-04 | 749 | 97 | 12 | GO:0005509 |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 4.86e-10 | 10 | 96 | 5 | GO:0097105 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 8.88e-10 | 11 | 96 | 5 | GO:0097104 | |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 2.46e-09 | 13 | 96 | 5 | GO:0097090 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 8.25e-09 | 16 | 96 | 5 | GO:0007158 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 4.77e-06 | 93 | 96 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 5.38e-06 | 8 | 96 | 3 | GO:1902474 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 5.38e-06 | 8 | 96 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane organization | 6.22e-06 | 56 | 96 | 5 | GO:0001941 | |
| GeneOntologyBiologicalProcess | terminal button organization | 8.04e-06 | 9 | 96 | 3 | GO:0072553 | |
| GeneOntologyBiologicalProcess | presynapse assembly | 8.77e-06 | 60 | 96 | 5 | GO:0099054 | |
| GeneOntologyBiologicalProcess | membrane assembly | 1.21e-05 | 64 | 96 | 5 | GO:0071709 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 1.30e-05 | 65 | 96 | 5 | GO:0098815 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 2.09e-05 | 12 | 96 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | calcium ion transport from cytosol to endoplasmic reticulum | 2.14e-05 | 2 | 96 | 2 | GO:1903515 | |
| GeneOntologyBiologicalProcess | membrane biogenesis | 2.30e-05 | 73 | 96 | 5 | GO:0044091 | |
| GeneOntologyBiologicalProcess | presynapse organization | 2.30e-05 | 73 | 96 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 2.88e-05 | 38 | 96 | 4 | GO:1902473 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | 3.25e-05 | 264 | 96 | 8 | GO:0099504 | |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange by nervous system process | 3.43e-05 | 14 | 96 | 3 | GO:0002087 | |
| GeneOntologyBiologicalProcess | negative regulation of excitatory postsynaptic potential | 4.27e-05 | 15 | 96 | 3 | GO:0090394 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 4.73e-05 | 43 | 96 | 4 | GO:0051968 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 5.19e-05 | 44 | 96 | 4 | GO:0098698 | |
| GeneOntologyBiologicalProcess | regulation of respiratory system process | 6.34e-05 | 17 | 96 | 3 | GO:0044065 | |
| GeneOntologyBiologicalProcess | territorial aggressive behavior | 6.41e-05 | 3 | 96 | 2 | GO:0002124 | |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 6.72e-05 | 148 | 96 | 6 | GO:1902414 | |
| GeneOntologyBiologicalProcess | synaptic vesicle endocytosis | 8.60e-05 | 96 | 96 | 5 | GO:0048488 | |
| GeneOntologyBiologicalProcess | synapse assembly | 9.59e-05 | 308 | 96 | 8 | GO:0007416 | |
| GeneOntologyBiologicalProcess | presynaptic endocytosis | 1.15e-04 | 102 | 96 | 5 | GO:0140238 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | 1.28e-04 | 321 | 96 | 8 | GO:0099003 | |
| GeneOntologyBiologicalProcess | male courtship behavior | 1.28e-04 | 4 | 96 | 2 | GO:0008049 | |
| GeneOntologyBiologicalProcess | synaptic vesicle clustering | 1.41e-04 | 22 | 96 | 3 | GO:0097091 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 1.71e-04 | 111 | 96 | 5 | GO:0036465 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 1.84e-04 | 24 | 96 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | protein localization to synapse | 2.01e-04 | 115 | 96 | 5 | GO:0035418 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 2.09e-04 | 25 | 96 | 3 | GO:2000311 | |
| GeneOntologyBiologicalProcess | cytosol to endoplasmic reticulum transport | 2.12e-04 | 5 | 96 | 2 | GO:0046967 | |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange | 2.64e-04 | 27 | 96 | 3 | GO:0043576 | |
| GeneOntologyBiologicalProcess | inhibitory postsynaptic potential | 2.64e-04 | 27 | 96 | 3 | GO:0060080 | |
| GeneOntologyBiologicalProcess | cell junction assembly | NLGN4Y IQSEC2 SPTBN2 NLGN1 NLGN3 NLGN4X TJP1 ELAVL2 NLGN2 TNS1 | 3.17e-04 | 569 | 96 | 10 | GO:0034329 |
| GeneOntologyBiologicalProcess | phosphatidylinositol acyl-chain remodeling | 3.18e-04 | 6 | 96 | 2 | GO:0036149 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 3.37e-04 | 71 | 96 | 4 | GO:0099084 | |
| GeneOntologyBiologicalProcess | synapse organization | NLGN4Y IQSEC2 SPTBN2 NLGN1 PTPRT NLGN3 NLGN4X MTMR2 ELAVL2 NLGN2 LNX1 | 3.40e-04 | 685 | 96 | 11 | GO:0050808 |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 3.56e-04 | 130 | 96 | 5 | GO:0060079 | |
| GeneOntologyBiologicalProcess | regulation of synapse assembly | 3.65e-04 | 202 | 96 | 6 | GO:0051963 | |
| GeneOntologyBiologicalProcess | adult behavior | 3.75e-04 | 203 | 96 | 6 | GO:0030534 | |
| GeneOntologyBiologicalProcess | social behavior | 3.95e-04 | 74 | 96 | 4 | GO:0035176 | |
| GeneOntologyBiologicalProcess | biological process involved in intraspecies interaction between organisms | 4.37e-04 | 76 | 96 | 4 | GO:0051703 | |
| GeneOntologyBiologicalProcess | courtship behavior | 4.43e-04 | 7 | 96 | 2 | GO:0007619 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB4 DSC3 NLGN4Y FNDC3A NLGN1 PTPRT GSTP1 NLGN3 NLGN4X HMCN1 BAIAP2L1 TJP1 SMARCC2 NLGN2 | 4.49e-04 | 1077 | 96 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of cellular localization | ATG7 IQSEC2 SLC30A8 MYO18A NLGN1 PLA2G4E ADAM22 CEMIP NLGN3 MTMR2 ERP29 NLGN2 GNAO1 MRAP2 MMP13 | 4.64e-04 | 1212 | 96 | 15 | GO:0060341 |
| GeneOntologyBiologicalProcess | cerebellum development | 4.84e-04 | 139 | 96 | 5 | GO:0021549 | |
| GeneOntologyBiologicalProcess | cell junction organization | NLGN4Y IQSEC2 SPTBN2 NLGN1 PTPRT NLGN3 NLGN4X TJP1 MTMR2 ELAVL2 NLGN2 LNX1 TNS1 | 5.71e-04 | 974 | 96 | 13 | GO:0034330 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.74e-04 | 35 | 96 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of dendritic spine morphogenesis | 5.89e-04 | 8 | 96 | 2 | GO:0061002 | |
| GeneOntologyBiologicalProcess | brainstem development | 5.89e-04 | 8 | 96 | 2 | GO:0003360 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 6.04e-04 | 309 | 96 | 7 | GO:1901888 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 6.24e-04 | 147 | 96 | 5 | GO:0099565 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 6.52e-04 | 313 | 96 | 7 | GO:0099173 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse assembly | 6.99e-04 | 86 | 96 | 4 | GO:0051965 | |
| GeneOntologyBiologicalProcess | metencephalon development | 7.47e-04 | 153 | 96 | 5 | GO:0022037 | |
| GeneOntologyBiologicalProcess | cerebellar Purkinje cell layer development | 7.91e-04 | 39 | 96 | 3 | GO:0021680 | |
| GeneOntologyBiologicalProcess | behavior | AFF2 ATG7 NLGN4Y SPTBN2 NLGN1 ADAM22 NLGN3 NLGN4X ELAVL4 NLGN2 GNAO1 MRAP2 | 8.71e-04 | 891 | 96 | 12 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 9.00e-04 | 92 | 96 | 4 | GO:0051966 | |
| GeneOntologyBiologicalProcess | respiratory gaseous exchange by respiratory system | 9.37e-04 | 93 | 96 | 4 | GO:0007585 | |
| GeneOntologyBiologicalProcess | positive regulation of inhibitory postsynaptic potential | 9.42e-04 | 10 | 96 | 2 | GO:0097151 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | TSPOAP1 NLGN4Y IQSEC2 NLGN1 NLGN3 NLGN4X MTMR2 NLGN2 GNAO1 ATP2A2 | 1.03e-03 | 663 | 96 | 10 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | TSPOAP1 NLGN4Y IQSEC2 NLGN1 NLGN3 NLGN4X MTMR2 NLGN2 GNAO1 ATP2A2 | 1.05e-03 | 664 | 96 | 10 | GO:0099177 |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 1.05e-03 | 43 | 96 | 3 | GO:2000463 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 1.15e-03 | 11 | 96 | 2 | GO:0097119 | |
| GeneOntologyBiologicalProcess | regulation of protein secretion | 1.25e-03 | 350 | 96 | 7 | GO:0050708 | |
| GeneOntologyBiologicalProcess | central nervous system development | ATP5PB HSPG2 AFF2 ATG7 NLGN4Y SPTBN2 ARHGAP35 ADAM22 GSTP1 ZNF430 NLGN3 NLGN4X ATXN2 ELAVL4 | 1.26e-03 | 1197 | 96 | 14 | GO:0007417 |
| GeneOntologyBiologicalProcess | cellular component maintenance | 1.27e-03 | 101 | 96 | 4 | GO:0043954 | |
| GeneOntologyBiologicalProcess | regulation of presynapse organization | 1.28e-03 | 46 | 96 | 3 | GO:0099174 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 1.36e-03 | 175 | 96 | 5 | GO:0031644 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 1.37e-03 | 47 | 96 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | modulation of inhibitory postsynaptic potential | 1.37e-03 | 12 | 96 | 2 | GO:0098828 | |
| GeneOntologyBiologicalProcess | insulin processing | 1.37e-03 | 12 | 96 | 2 | GO:0030070 | |
| GeneOntologyBiologicalProcess | import into cell | HSPG2 ATG7 NLGN4Y SLC30A8 MYO18A NLGN1 LRP1B SLC7A8 NLGN3 NLGN4X ATXN2 MTMR2 NLGN2 | 1.40e-03 | 1074 | 96 | 13 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 1.54e-03 | 180 | 96 | 5 | GO:0060078 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | ATG7 IQSEC2 SLC30A8 MYO18A NLGN1 ADAM22 CEMIP NLGN3 ERP29 NLGN2 GNAO1 MRAP2 MMP13 | 1.56e-03 | 1087 | 96 | 13 | GO:0032880 |
| GeneOntologyBiologicalProcess | endocytosis | HSPG2 ATG7 NLGN4Y MYO18A NLGN1 LRP1B NLGN3 NLGN4X ATXN2 MTMR2 NLGN2 | 1.59e-03 | 827 | 96 | 11 | GO:0006897 |
| GeneOntologyBiologicalProcess | aggressive behavior | 1.62e-03 | 13 | 96 | 2 | GO:0002118 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 1.74e-03 | 591 | 96 | 9 | GO:1903829 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor binding | 1.88e-03 | 14 | 96 | 2 | GO:1900121 | |
| GeneOntologyCellularComponent | symmetric, GABA-ergic, inhibitory synapse | 4.54e-10 | 4 | 98 | 4 | GO:0098983 | |
| GeneOntologyCellularComponent | excitatory synapse | 3.89e-08 | 107 | 98 | 8 | GO:0060076 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 8.09e-08 | 24 | 98 | 5 | GO:0098985 | |
| GeneOntologyCellularComponent | symmetric synapse | 3.14e-07 | 13 | 98 | 4 | GO:0032280 | |
| GeneOntologyCellularComponent | inhibitory synapse | 3.15e-07 | 31 | 98 | 5 | GO:0060077 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 4.77e-06 | 201 | 98 | 8 | GO:0099634 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | NLGN4Y IQSEC2 NLGN1 ADAM22 PTPRT NLGN3 NLGN4X MTMR2 ELAVL2 NLGN2 LNX1 | 3.40e-05 | 523 | 98 | 11 | GO:0098984 |
| GeneOntologyCellularComponent | glycinergic synapse | 1.07e-04 | 20 | 98 | 3 | GO:0098690 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.21e-04 | 405 | 98 | 9 | GO:0045211 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 1.23e-04 | 164 | 98 | 6 | GO:0098982 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.06e-04 | 477 | 98 | 9 | GO:0032279 | |
| GeneOntologyCellularComponent | synaptic membrane | NLGN4Y IQSEC2 NLGN1 ADAM22 PTPRT NLGN3 NLGN4X MTMR2 NLGN2 GNAO1 | 4.09e-04 | 583 | 98 | 10 | GO:0097060 |
| GeneOntologyCellularComponent | glutamatergic synapse | TSPOAP1 NLGN4Y IQSEC2 SPTBN2 NLGN1 ADAM22 PTPRT NLGN3 NLGN4X ELAVL2 ELAVL4 GNAO1 | 4.36e-04 | 817 | 98 | 12 | GO:0098978 |
| GeneOntologyCellularComponent | ribbon synapse | 4.49e-04 | 32 | 98 | 3 | GO:0097470 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.95e-04 | 503 | 98 | 9 | GO:0099572 | |
| GeneOntologyCellularComponent | anchoring junction | HSPG2 FLNB HYOU1 DSC3 SPTBN2 LAMA1 HMCN1 BAIAP2L1 TJP1 PLAU MMP13 ATP2A2 TNS1 | 6.27e-04 | 976 | 98 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | intercellular canaliculus | 7.67e-04 | 9 | 98 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 7.67e-04 | 9 | 98 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 8.68e-04 | 157 | 98 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynapse | NLGN4Y IQSEC2 SPTBN2 NLGN1 ADAM22 PTPRT NLGN3 NLGN4X MTMR2 ELAVL4 NLGN2 GNAO1 LNX1 | 9.26e-04 | 1018 | 98 | 13 | GO:0098794 |
| GeneOntologyCellularComponent | platelet dense tubular network | 1.16e-03 | 11 | 98 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.31e-03 | 46 | 98 | 3 | GO:0005790 | |
| GeneOntologyCellularComponent | endoplasmic reticulum chaperone complex | 1.64e-03 | 13 | 98 | 2 | GO:0034663 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 2.69e-03 | 59 | 98 | 3 | GO:0098636 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 2.83e-03 | 17 | 98 | 2 | GO:0098637 | |
| MousePheno | abnormal nephron morphogenesis | 2.84e-05 | 2 | 75 | 2 | MP:0012024 | |
| MousePheno | abnormal S-shaped body morphology | 2.84e-05 | 2 | 75 | 2 | MP:0012026 | |
| MousePheno | decreased length of long bones | HSPG2 FLNB COL12A1 SPTBN2 FNDC3A DPP3 CEMIP SLC7A8 ZFHX4 MMP13 | 6.25e-05 | 409 | 75 | 10 | MP:0004686 |
| Domain | Nlgn | 2.90e-12 | 5 | 94 | 5 | IPR000460 | |
| Domain | Carboxylesterase_B_CS | 3.62e-09 | 13 | 94 | 5 | IPR019819 | |
| Domain | CARBOXYLESTERASE_B_2 | 5.60e-09 | 14 | 94 | 5 | PS00941 | |
| Domain | COesterase | 5.60e-09 | 14 | 94 | 5 | PF00135 | |
| Domain | CarbesteraseB | 5.60e-09 | 14 | 94 | 5 | IPR002018 | |
| Domain | NLGN4 | 2.51e-05 | 2 | 94 | 2 | IPR030025 | |
| Domain | - | 3.04e-05 | 119 | 94 | 6 | 3.40.50.1820 | |
| Domain | AB_hydrolase | 3.04e-05 | 119 | 94 | 6 | IPR029058 | |
| Domain | P-type_ATPase_IIA | 7.49e-05 | 3 | 94 | 2 | IPR005782 | |
| Domain | ELAD_HUD_SF | 1.49e-04 | 4 | 94 | 2 | IPR006548 | |
| Domain | fn3 | 1.68e-04 | 162 | 94 | 6 | PF00041 | |
| Domain | FN3 | 3.45e-04 | 185 | 94 | 6 | SM00060 | |
| Domain | EGF-like_CS | 3.49e-04 | 261 | 94 | 7 | IPR013032 | |
| Domain | EGF_2 | 3.83e-04 | 265 | 94 | 7 | PS01186 | |
| Domain | FN3 | 5.07e-04 | 199 | 94 | 6 | PS50853 | |
| Domain | PLA2_B | 5.18e-04 | 7 | 94 | 2 | PF01735 | |
| Domain | PLA2C | 5.18e-04 | 7 | 94 | 2 | PS51210 | |
| Domain | LysoPLipase_cat_dom | 5.18e-04 | 7 | 94 | 2 | IPR002642 | |
| Domain | PLAc | 5.18e-04 | 7 | 94 | 2 | SM00022 | |
| Domain | FN3_dom | 6.57e-04 | 209 | 94 | 6 | IPR003961 | |
| Domain | LAMININ_IVA | 6.88e-04 | 8 | 94 | 2 | PS51115 | |
| Domain | Laminin_B | 6.88e-04 | 8 | 94 | 2 | PF00052 | |
| Domain | LamB | 6.88e-04 | 8 | 94 | 2 | SM00281 | |
| Domain | Laminin_IV | 6.88e-04 | 8 | 94 | 2 | IPR000034 | |
| Domain | Hud_Sxl_RNA | 1.10e-03 | 10 | 94 | 2 | IPR002343 | |
| Domain | Hydrolase_3 | 1.10e-03 | 10 | 94 | 2 | PF08282 | |
| Domain | Growth_fac_rcpt_ | 1.15e-03 | 156 | 94 | 5 | IPR009030 | |
| Domain | EGF | 1.21e-03 | 235 | 94 | 6 | SM00181 | |
| Domain | Laminin_G_1 | 1.34e-03 | 11 | 94 | 2 | PF00054 | |
| Domain | EGF-like_dom | 1.62e-03 | 249 | 94 | 6 | IPR000742 | |
| Domain | EGF_1 | 1.83e-03 | 255 | 94 | 6 | PS00022 | |
| Domain | - | EPHB4 HSPG2 FLNB COL12A1 TSPOAP1 FNDC3A PTPRT HMCN1 ZPBP2 MYBPC1 | 1.84e-03 | 663 | 94 | 10 | 2.60.40.10 |
| Domain | ATPase_P-typ_TM_dom | 2.87e-03 | 16 | 94 | 2 | IPR023298 | |
| Domain | - | 2.87e-03 | 16 | 94 | 2 | 1.20.1110.10 | |
| Domain | Ig-like_fold | EPHB4 HSPG2 FLNB COL12A1 TSPOAP1 FNDC3A PTPRT HMCN1 ZPBP2 MYBPC1 | 2.90e-03 | 706 | 94 | 10 | IPR013783 |
| Domain | Laminin_G | 3.12e-03 | 58 | 94 | 3 | IPR001791 | |
| Domain | ATPase_P-typ_cation-transptr_C | 3.24e-03 | 17 | 94 | 2 | IPR006068 | |
| Domain | Cation_ATPase_C | 3.24e-03 | 17 | 94 | 2 | PF00689 | |
| Domain | Acyl_Trfase/lysoPLipase | 3.24e-03 | 17 | 94 | 2 | IPR016035 | |
| Domain | PTPc_motif | 3.27e-03 | 59 | 94 | 3 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.27e-03 | 59 | 94 | 3 | IPR003595 | |
| Domain | LH2 | 3.64e-03 | 18 | 94 | 2 | SM00308 | |
| Domain | Cation_ATPase_N | 3.64e-03 | 18 | 94 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 3.64e-03 | 18 | 94 | 2 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.05e-03 | 19 | 94 | 2 | IPR004014 | |
| Domain | - | 4.95e-03 | 21 | 94 | 2 | 2.60.60.20 | |
| Domain | PLAT | 4.95e-03 | 21 | 94 | 2 | PF01477 | |
| Domain | PLAT/LH2_dom | 4.95e-03 | 21 | 94 | 2 | IPR001024 | |
| Domain | PLAT | 4.95e-03 | 21 | 94 | 2 | PS50095 | |
| Domain | ConA-like_dom | 5.00e-03 | 219 | 94 | 5 | IPR013320 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 9.26e-07 | 32 | 80 | 5 | MM15326 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.09e-06 | 33 | 80 | 5 | M39875 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 2.77e-06 | 18 | 80 | 4 | M48098 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.58e-05 | 56 | 80 | 5 | M27616 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.80e-05 | 67 | 80 | 5 | MM15327 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.33e-04 | 87 | 80 | 5 | M27617 | |
| Pubmed | 1.60e-13 | 5 | 98 | 5 | 37865312 | ||
| Pubmed | Synapse formation: if it looks like a duck and quacks like a duck ... | 1.60e-13 | 5 | 98 | 5 | 10996085 | |
| Pubmed | 9.59e-13 | 6 | 98 | 5 | 21838267 | ||
| Pubmed | 9.59e-13 | 6 | 98 | 5 | 29724786 | ||
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 8.91e-12 | 8 | 98 | 5 | 30871858 | |
| Pubmed | MRPS31 ATP5PB FLNB NCALD HSP90B2P TSPOAP1 IQSEC2 MYO18A MCCC2 ARHGAP35 LRP1B NDUFS2 ADAM22 NDUFA12 PPP5C TJP1 SMARCC2 ELAVL4 EIF3B ATP2A2 | 5.19e-11 | 1139 | 98 | 20 | 36417873 | |
| Pubmed | Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. | 5.93e-11 | 4 | 98 | 4 | 12669065 | |
| Pubmed | Homodimerization and isoform-specific heterodimerization of neuroligins. | 5.93e-11 | 4 | 98 | 4 | 22671294 | |
| Pubmed | 5.93e-11 | 4 | 98 | 4 | 16077734 | ||
| Pubmed | 7.30e-11 | 11 | 98 | 5 | 32973045 | ||
| Pubmed | 7.30e-11 | 11 | 98 | 5 | 26403076 | ||
| Pubmed | Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. | 2.96e-10 | 5 | 98 | 4 | 15620359 | |
| Pubmed | ATP5PB FLNB HSP90B2P HYOU1 IQSEC2 SPTBN2 MYO18A ARHGAP35 NDUFS2 ADAM22 GSTP1 NLGN3 SLC44A1 NDUFA12 TJP1 MTMR2 SMARCC2 GNAO1 FH ATP2A2 TNS1 | 4.23e-10 | 1431 | 98 | 21 | 37142655 | |
| Pubmed | 4.70e-10 | 15 | 98 | 5 | 18227507 | ||
| Pubmed | 7.39e-09 | 9 | 98 | 4 | 9278515 | ||
| Pubmed | DSCAM Deficiency Leads to Premature Spine Maturation and Autism-like Behaviors. | 1.01e-08 | 26 | 98 | 5 | 34848499 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 28607166 | ||
| Pubmed | Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits. | 2.17e-08 | 3 | 98 | 3 | 29100073 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 26291161 | ||
| Pubmed | Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. | 2.17e-08 | 3 | 98 | 3 | 17897391 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 16982420 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 32011705 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 27217145 | ||
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 18628683 | ||
| Pubmed | Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina. | 2.17e-08 | 3 | 98 | 3 | 21282647 | |
| Pubmed | Role of Elavl-like RNA-binding protein in retinal development and signal transduction. | 2.57e-08 | 31 | 98 | 5 | 39307290 | |
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 30056576 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 20579107 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 17292328 | ||
| Pubmed | 8.66e-08 | 4 | 98 | 3 | 32719346 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP5PB HSP90B2P TSPOAP1 MYO18A ASH2L NDUFS2 ADAM22 ELAVL2 ELAVL4 GNAO1 ATP2A2 ATP2A3 | 1.90e-07 | 621 | 98 | 12 | 22794259 |
| Pubmed | 5-HT modulation of a medial septal circuit tunes social memory stability. | 2.16e-07 | 5 | 98 | 3 | 34616037 | |
| Pubmed | Neuroligins Are Selectively Essential for NMDAR Signaling in Cerebellar Stellate Interneurons. | 2.16e-07 | 5 | 98 | 3 | 27581450 | |
| Pubmed | 2.16e-07 | 5 | 98 | 3 | 28939043 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 29742426 | ||
| Pubmed | 4.31e-07 | 6 | 98 | 3 | 19816407 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 4.31e-07 | 6 | 98 | 3 | 8576240 | |
| Pubmed | Control of excitatory and inhibitory synapse formation by neuroligins. | 1.20e-06 | 8 | 98 | 3 | 15681343 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.38e-06 | 281 | 98 | 8 | 28706196 | |
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 34919427 | ||
| Pubmed | 1.80e-06 | 9 | 98 | 3 | 23010509 | ||
| Pubmed | FLNB HYOU1 SPTBN2 GSTP1 TJP1 OASL ZNF638 SMARCC2 FH ATP2A2 CLUH | 2.40e-06 | 653 | 98 | 11 | 22586326 | |
| Pubmed | IQSEC2 SPTBN2 ADAM22 NLGN3 FRY ATXN2 TJP1 ELAVL2 SMARCC2 ELAVL4 NLGN2 GNAO1 TNS1 | 3.18e-06 | 963 | 98 | 13 | 28671696 | |
| Pubmed | MRPS31 EPHB4 ATP5PB HYOU1 DSC3 SPTBN2 MYO18A FNDC3A MCCC2 NDUFS2 NDUFA12 PPP5C ERP29 DNAJB5 ATP2A2 CLUH | 3.98e-06 | 1487 | 98 | 16 | 33957083 | |
| Pubmed | Advancing the understanding of autism disease mechanisms through genetics. | 6.08e-06 | 13 | 98 | 3 | 27050589 | |
| Pubmed | 7.72e-06 | 14 | 98 | 3 | 12475965 | ||
| Pubmed | Translational animal models of autism and neurodevelopmental disorders. | 7.72e-06 | 14 | 98 | 3 | 23226954 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 8668530 | ||
| Pubmed | The structure and expression of the human neuroligin-3 gene. | 7.86e-06 | 2 | 98 | 2 | 10767552 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 27782075 | ||
| Pubmed | Not all neuroligin 3 and 4X missense variants lead to significant functional inactivation. | 7.86e-06 | 2 | 98 | 2 | 28948087 | |
| Pubmed | Cochlear ribbon synapse maturation requires Nlgn1 and Nlgn3. | 7.86e-06 | 2 | 98 | 2 | 35992071 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 27805570 | ||
| Pubmed | Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. | 7.86e-06 | 2 | 98 | 2 | 16648374 | |
| Pubmed | A substitution involving the NLGN4 gene associated with autistic behavior in the Greek population. | 7.86e-06 | 2 | 98 | 2 | 19645625 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 9425170 | ||
| Pubmed | Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. | 7.86e-06 | 2 | 98 | 2 | 15274046 | |
| Pubmed | Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. | 7.86e-06 | 2 | 98 | 2 | 22983708 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23183221 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 24855039 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18607064 | ||
| Pubmed | Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder. | 7.86e-06 | 2 | 98 | 2 | 37001827 | |
| Pubmed | Reduced susceptibility to induced seizures in the Neuroligin-3(R451C) mouse model of autism. | 7.86e-06 | 2 | 98 | 2 | 25592157 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19650915 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 11329178 | ||
| Pubmed | Characterization of the neuroligin gene family expression and evolution in zebrafish. | 7.86e-06 | 2 | 98 | 2 | 20034102 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 36479216 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19962989 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18189281 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 19889999 | ||
| Pubmed | Disorder-associated mutations lead to functional inactivation of neuroligins. | 7.86e-06 | 2 | 98 | 2 | 15150161 | |
| Pubmed | Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. | 7.86e-06 | 2 | 98 | 2 | 15622415 | |
| Pubmed | Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. | 7.86e-06 | 2 | 98 | 2 | 10892652 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 25270119 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18434543 | ||
| Pubmed | NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening. | 7.86e-06 | 2 | 98 | 2 | 29278843 | |
| Pubmed | Analysis of the genes encoding neuroligins NLGN3 and NLGN4 in Bulgarian patients with autism. | 7.86e-06 | 2 | 98 | 2 | 23431752 | |
| Pubmed | Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice. | 7.86e-06 | 2 | 98 | 2 | 37080762 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 16508939 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 18295663 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 29106499 | ||
| Pubmed | NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. | 7.86e-06 | 2 | 98 | 2 | 15389766 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 26456829 | ||
| Pubmed | Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro. | 7.86e-06 | 2 | 98 | 2 | 24104404 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 31013625 | ||
| Pubmed | A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y. | 7.86e-06 | 2 | 98 | 2 | 32243781 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 22989184 | ||
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 21885870 | ||
| Pubmed | Variations analysis of NLGN3 and NLGN4X gene in Chinese autism patients. | 7.86e-06 | 2 | 98 | 2 | 24570023 | |
| Pubmed | 7.86e-06 | 2 | 98 | 2 | 23851596 | ||
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | 8.61e-06 | 607 | 98 | 10 | 39147351 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MRPS31 FLNB HYOU1 DSC3 SPTBN2 MYO18A NDUFS2 GSTP1 BAIAP2L1 ATXN2 TJP1 OASL ZNF638 EIF3B | 1.16e-05 | 1257 | 98 | 14 | 36526897 |
| Pubmed | 1.18e-05 | 497 | 98 | 9 | 23414517 | ||
| Pubmed | MRPS31 ATP5PB FLNB NCALD HYOU1 SPTBN2 MYO18A PLA2G4D NDUFA12 TJP1 SMARCC2 GNAO1 ATP2A2 ATP2A3 MYBPC1 | 1.23e-05 | 1442 | 98 | 15 | 35575683 | |
| Pubmed | 1.31e-05 | 274 | 98 | 7 | 34244482 | ||
| Pubmed | IgSF21 promotes differentiation of inhibitory synapses via binding to neurexin2α. | 1.72e-05 | 18 | 98 | 3 | 28864826 | |
| Pubmed | Loss of transforming growth factor-beta 2 leads to impairment of central synapse function. | 1.72e-05 | 18 | 98 | 3 | 18854036 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP5PB FLNB HYOU1 AFF2 MCCC2 DPP3 SMARCC2 ERP29 EIF3B FH ATP2A2 | 1.76e-05 | 807 | 98 | 11 | 30575818 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FLNB ATG7 FOLH1 NLGN4Y KIAA0232 MCCC2 ARHGAP35 ZNF440 NIT2 SGK2 NLGN3 ATXN2 TJP1 ZNF638 NLGN2 | 1.79e-05 | 1489 | 98 | 15 | 28611215 |
| Pubmed | Developmental expression and subcellular distribution of synaptotagmin 11 in rat hippocampus. | 2.35e-05 | 3 | 98 | 2 | 22960622 | |
| Interaction | GLDC interactions | ATP5PB FLNB DSC3 SPTBN2 MYO18A PPP5C ATXN2 TJP1 SMARCC2 CLUH | 3.07e-06 | 321 | 96 | 10 | int:GLDC |
| Interaction | SSUH2 interactions | 4.95e-06 | 199 | 96 | 8 | int:SSUH2 | |
| Interaction | KCTD13 interactions | ATP5PB FLNB HYOU1 IQSEC2 SPTBN2 MYO18A ARHGAP35 NDUFS2 ADAM22 NLGN3 SLC44A1 NDUFA12 TJP1 MTMR2 SMARCC2 GNAO1 FH LNX1 ATP2A2 TNS1 | 7.44e-06 | 1394 | 96 | 20 | int:KCTD13 |
| Interaction | ACO2 interactions | 1.48e-05 | 304 | 96 | 9 | int:ACO2 | |
| Interaction | NRXN2 interactions | 2.23e-05 | 12 | 96 | 3 | int:NRXN2 | |
| GeneFamily | Fibronectin type III domain containing | 3.31e-05 | 160 | 69 | 6 | 555 | |
| GeneFamily | ATPases Ca2+ transporting | 5.08e-04 | 9 | 69 | 2 | 1209 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | AFF2 TSPOAP1 NLGN1 AMER3 ARHGAP35 LRP1B PTPRT SGK2 CEMIP FRY NLGN4X ZFHX4 ELAVL2 SMARCC2 ELAVL4 GNAO1 | 3.31e-06 | 1106 | 98 | 16 | M39071 |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 160 | 98 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.65e-08 | 160 | 98 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-07 | 175 | 98 | 7 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 184 | 98 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 193 | 98 | 7 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 193 | 98 | 7 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.83e-06 | 179 | 98 | 6 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | droplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 184 | 98 | 6 | e02859bbac36dbbd55d7ae8cb5e46b764d7c6381 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.32e-06 | 184 | 98 | 6 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 194 | 98 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 194 | 98 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.64e-06 | 195 | 98 | 6 | a52685f76eca269a7d2de8dfc317439483e233fa | |
| ToppCell | Parenchymal-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.64e-06 | 195 | 98 | 6 | 224deeba2f60def6543a55bb4f5ee6c7fdab3f02 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 1a3d29a580d1b405a74869a1da3e818c581fc559 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E---L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 6f9ed8fe9cda91185c3a1a675353e11b8fec6ef1 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | 86705dfc05b3e1576543b93883c88fb55b742855 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.36e-06 | 200 | 98 | 6 | db194b4f524fd008b3c5b4b6014b436190a1b87a | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.51e-05 | 141 | 98 | 5 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.05e-05 | 73 | 98 | 4 | 562f2264476e5402eda1cf0c8b28c3d325cbc6f1 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.05e-05 | 73 | 98 | 4 | 6b1971d4a50a1f644f70b3e08b9a825434cc6f0c | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.51e-05 | 168 | 98 | 5 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.71e-05 | 170 | 98 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 10x5'-GI_small-bowel-Mast|GI_small-bowel / Manually curated celltypes from each tissue | 4.15e-05 | 174 | 98 | 5 | e94c980b25edfd0e8598c416828801fcc00e8ead | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC2|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.15e-05 | 174 | 98 | 5 | 60ee7c6f1b6972e6647a16848087cc60e0060bbe | |
| ToppCell | 10x5'-GI_small-bowel-Mast-Mast_cells|GI_small-bowel / Manually curated celltypes from each tissue | 4.15e-05 | 174 | 98 | 5 | 05525bf0a2bde2be4f7c147b17a24530ce8819e0 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.15e-05 | 174 | 98 | 5 | 6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.26e-05 | 175 | 98 | 5 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-05 | 176 | 98 | 5 | c6484334187f64cd00cd35e77d8ae436556b4260 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 177 | 98 | 5 | 43883b65b1e03043a24fc40c84c50bac81960c12 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 177 | 98 | 5 | 9de6a82b7fb72d20361947f7ac95bb1fa73fc2ff | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.50e-05 | 177 | 98 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.62e-05 | 178 | 98 | 5 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-05 | 178 | 98 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.75e-05 | 179 | 98 | 5 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 180 | 98 | 5 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 180 | 98 | 5 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | 3'_v3-bone_marrow-Mast|bone_marrow / Manually curated celltypes from each tissue | 4.87e-05 | 180 | 98 | 5 | b37ee81b792213d6595b4ec65d04bc35d83321c7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 180 | 98 | 5 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cells|bone_marrow / Manually curated celltypes from each tissue | 5.00e-05 | 181 | 98 | 5 | 30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a | |
| ToppCell | Control-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 5.41e-05 | 184 | 98 | 5 | b5c1f57f0356969cfb0e1dac764684fc5583bc04 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-05 | 184 | 98 | 5 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.69e-05 | 186 | 98 | 5 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-05 | 187 | 98 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 187 | 98 | 5 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 187 | 98 | 5 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 191 | 98 | 5 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 191 | 98 | 5 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | facs-Pancreas|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 191 | 98 | 5 | d48e5f67d384226add7d7fb2a124954136e09a82 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 191 | 98 | 5 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-immature_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.61e-05 | 192 | 98 | 5 | 5af3b2b38495e925497c48f605d618bbf970965d | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.61e-05 | 192 | 98 | 5 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 6.61e-05 | 192 | 98 | 5 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 192 | 98 | 5 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | BL-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.95e-05 | 194 | 98 | 5 | 2932f704656ca368565ec12f3452af3b18e8df12 | |
| ToppCell | droplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.95e-05 | 194 | 98 | 5 | 1ac52b00ea0b0ddbd04f5d85fa8c086980a78926 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 194 | 98 | 5 | f6c9cc362ccdbc7e790f7c8d1c56cab3557c5306 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.12e-05 | 195 | 98 | 5 | cc3d6f98d310e8840ff497d7258c5ccf54e6c624 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 196 | 98 | 5 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | Leuk-UTI-Myeloid-cDC2|Leuk-UTI / Disease, Lineage and Cell Type | 7.29e-05 | 196 | 98 | 5 | 50465a082f03201936733c55af73bc32e1bdd024 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-05 | 196 | 98 | 5 | a58bdf9de05d13d84211e09a933679d485bf8ab4 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 197 | 98 | 5 | deefb492b5f0e6014144bd465c4a6ae4206e8739 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.47e-05 | 197 | 98 | 5 | a6aaa6faea348291023f0bc4b0f83fbc67d91da6 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-MOP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.47e-05 | 197 | 98 | 5 | cbfe62cd4c38ae3c893b869e8af8defb9777df25 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.65e-05 | 198 | 98 | 5 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 7.65e-05 | 198 | 98 | 5 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.65e-05 | 198 | 98 | 5 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 198 | 98 | 5 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-Venous_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.83e-05 | 199 | 98 | 5 | 70e05d7c0c68c28754ce0e72434b205aed6287ae | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 7.83e-05 | 199 | 98 | 5 | f89d67e3d8cd48ef5c30a5ad71764f4ebbc8bcb3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Biopsy_IPF-Mesenchymal-Mesothelial_cells|Biopsy_IPF / Sample group, Lineage and Cell type | 8.02e-05 | 200 | 98 | 5 | 553386523fd8f8f36617a0d81032224b7ddce442 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | supra_basal_cell|World / shred by cell class for nasal brushing | 8.02e-05 | 200 | 98 | 5 | 542bdcec563644e01887fd85eb158b32db439b03 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Intermediate|10w / Sample Type, Dataset, Time_group, and Cell type. | 8.02e-05 | 200 | 98 | 5 | e5a8647c47a49c8c90c78d681193946de103d8ff | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Neuronal-Excitatory-eB(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | 51265e30f1138fd79733001d0db759f3dab0aaeb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.02e-05 | 200 | 98 | 5 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 8.02e-05 | 200 | 98 | 5 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 8.02e-05 | 200 | 98 | 5 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.23e-05 | 104 | 98 | 4 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | LPS-antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.84e-04 | 128 | 98 | 4 | cfc73cb803ba50a4a8709e19e70e1e399118c849 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.01e-04 | 131 | 98 | 4 | 96d300958545714d18e905e860e95469c8ae4efa | |
| ToppCell | RA-06._Ventricular_Cardiomyocyte_II|RA / Chamber and Cluster_Paper | 2.07e-04 | 132 | 98 | 4 | 82674ec4b0a416e4f08372b86c2a475afe3f38a5 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.29e-04 | 54 | 98 | 3 | 7670a6eb185ae0d8c3c0cb17f8eaa9970355187b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.29e-04 | 54 | 98 | 3 | 79f804e73f859c0e8192d9e9e6ee2282f7f1691b | |
| ToppCell | frontal_cortex-Non-neuronal-oligodendrocyte-Oligo-Oligo_Serpinb1a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-04 | 137 | 98 | 4 | ca8fdbe66a854e6283b22179ec9359ea9e86cd8e | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.73e-04 | 142 | 98 | 4 | f4e4cde228149d5a536fbf0517ed71d81e296faf | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Macroglial-Astrocyte|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.73e-04 | 142 | 98 | 4 | 85e573616e54d41391b4ad8c3d38e4ca92112673 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-04 | 148 | 98 | 4 | 12fa2c4922f03803006c606b1b16e79441e3bb13 | |
| ToppCell | IIH-CD4-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.19e-04 | 148 | 98 | 4 | ec626a44cea83f2a0e5c27fc8182f96446d297ac | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-04 | 151 | 98 | 4 | f5ae450e3daa10540ca8437d05efe2d86ac70960 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HG-U133A | 1.61e-07 | 196 | 97 | 9 | 490_UP | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.96e-06 | 196 | 97 | 8 | 7357_DN | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 2.04e-06 | 197 | 97 | 8 | 3531_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 2.04e-06 | 197 | 97 | 8 | 6050_DN | |
| Drug | cyclizine | 1.04e-05 | 116 | 97 | 6 | CID000006726 | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.78e-05 | 191 | 97 | 7 | 2627_UP | |
| Drug | Letrozole [112809-51-5]; Down 200; 14uM; PC3; HT_HG-U133A | 1.90e-05 | 193 | 97 | 7 | 4240_DN | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 1.97e-05 | 194 | 97 | 7 | 6827_UP | |
| Drug | Tribenoside [10310-32-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.97e-05 | 194 | 97 | 7 | 3507_UP | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.03e-05 | 195 | 97 | 7 | 2653_UP | |
| Drug | Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 5279_DN | |
| Drug | Conessine [546-06-5]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 4191_UP | |
| Drug | Diflorasone Diacetate [33564-31-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 2798_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 4479_UP | |
| Drug | CP-863187 [668981-07-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 7512_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 5919_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 2.10e-05 | 196 | 97 | 7 | 2229_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 3801_DN | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; PC3; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 1217_UP | |
| Drug | ICI 182,780; Down 200; 1uM; PC3; HG-U133A | 2.17e-05 | 197 | 97 | 7 | 704_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A | 2.17e-05 | 197 | 97 | 7 | 5600_DN | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.24e-05 | 198 | 97 | 7 | 2841_UP | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.24e-05 | 198 | 97 | 7 | 5479_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.24e-05 | 198 | 97 | 7 | 4104_UP | |
| Drug | Cloxacillin sodium salt [642-78-4]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 2289_DN | |
| Drug | Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 2803_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A | 2.32e-05 | 199 | 97 | 7 | 1933_DN | |
| Drug | Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A | 2.32e-05 | 199 | 97 | 7 | 7516_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; HL60; HT_HG-U133A | 2.39e-05 | 200 | 97 | 7 | 6127_DN | |
| Drug | Nifurthiazole | 3.29e-05 | 15 | 97 | 3 | CID003607071 | |
| Drug | WR-151327 | 5.37e-05 | 3 | 97 | 2 | CID000100632 | |
| Drug | CC270 | 1.18e-04 | 59 | 97 | 4 | CID006918852 | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 1.42e-04 | 185 | 97 | 6 | 1226_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.42e-04 | 185 | 97 | 6 | 4707_UP | |
| Drug | Levonordefrin [829-74-3]; Up 200; 21.8uM; PC3; HT_HG-U133A | 1.51e-04 | 187 | 97 | 6 | 5854_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.64e-04 | 190 | 97 | 6 | 2629_UP | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HG-U133A | 1.69e-04 | 191 | 97 | 6 | 489_UP | |
| Drug | Methionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 1.74e-04 | 192 | 97 | 6 | 2831_UP | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.74e-04 | 192 | 97 | 6 | 7489_UP | |
| Drug | NSC-37538 | 1.78e-04 | 5 | 97 | 2 | CID000014464 | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.79e-04 | 193 | 97 | 6 | 4690_DN | |
| Drug | Bromperidol [10457-90-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.79e-04 | 193 | 97 | 6 | 2872_UP | |
| Drug | Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A | 1.84e-04 | 194 | 97 | 6 | 6769_UP | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.84e-04 | 194 | 97 | 6 | 6835_UP | |
| Drug | Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.84e-04 | 194 | 97 | 6 | 3840_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 1.84e-04 | 194 | 97 | 6 | 3779_DN | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.84e-04 | 194 | 97 | 6 | 4529_DN | |
| Drug | Simvastatin | MRPS31 COL12A1 DSPP SGK2 GSTP1 NLGN3 NPC1L1 PLAU MMP13 ATP2A2 | 1.86e-04 | 581 | 97 | 10 | ctd:D019821 |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 5313_UP | |
| Drug | Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 3455_UP | |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 2750_UP | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 1.89e-04 | 195 | 97 | 6 | 5428_DN | |
| Drug | 15d-PGJ2; Up 200; 10uM; SKMEL5; HG-U133A | 1.89e-04 | 195 | 97 | 6 | 564_UP | |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 5015_DN | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 5999_UP | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 3372_UP | |
| Drug | Tolazamide [1156-19-0]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 4003_DN | |
| Drug | Novobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 4392_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 1505_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 4806_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 2783_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 5236_UP | |
| Drug | Cromolyn disodium salt [15826-37-6]; Down 200; 7.8uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 5754_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 2818_DN | |
| Drug | Famprofazone [22881-35-2]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 6029_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.94e-04 | 196 | 97 | 6 | 5807_UP | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 2848_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 7335_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4815_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4557_DN | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 3639_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 7273_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 5249_UP | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 6466_DN | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 2654_UP | |
| Drug | troglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 1173_UP | |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4955_UP | |
| Drug | Ofloxacin [82419-36-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 2302_DN | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 6801_UP | |
| Drug | Ifenprodil tartrate [23210-58-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 5463_UP | |
| Drug | Gramine [87-52-5]; Down 200; 23uM; PC3; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 3999_DN | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 2.00e-04 | 197 | 97 | 6 | 610_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 197 | 97 | 6 | 4363_DN | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 6446_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 7096_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 2158_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 5334_UP | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 7509_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 2108_UP | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 3193_UP | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 5815_UP | |
| Drug | Betazole hydrochloride; Up 200; 27uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 1690_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 7224_UP | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 4081_DN | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 5393_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; PC3; HG-U133A | 2.05e-04 | 198 | 97 | 6 | 702_DN | |
| Drug | haloperidol; Down 200; 10uM; PC3; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 4468_DN | |
| Drug | Mephenesin [59-47-2]; Up 200; 22uM; MCF7; HT_HG-U133A | 2.05e-04 | 198 | 97 | 6 | 2304_UP | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 7311_DN | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.11e-04 | 199 | 97 | 6 | 7532_UP | |
| Disease | Brody myopathy (implicated_via_orthology) | 3.07e-05 | 3 | 95 | 2 | DOID:0050692 (implicated_via_orthology) | |
| Disease | meningitis (is_marker_for) | 6.13e-05 | 4 | 95 | 2 | DOID:9471 (is_marker_for) | |
| Disease | sclerosing cholangitis | 6.24e-05 | 66 | 95 | 4 | EFO_0004268 | |
| Disease | peritonitis (is_implicated_in) | 1.02e-04 | 5 | 95 | 2 | DOID:8283 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.35e-04 | 152 | 95 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cortical thickness | HSPG2 FLNB COL12A1 SPTBN2 LAMA1 ARHGAP35 ATXN2 MTMR2 ELAVL2 LNX1 TNS1 CLUH | 2.39e-04 | 1113 | 95 | 12 | EFO_0004840 |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 3.00e-04 | 99 | 95 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | status epilepticus (biomarker_via_orthology) | 3.12e-04 | 100 | 95 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | latent autoimmune diabetes in adults, type 2 diabetes mellitus | 3.64e-04 | 9 | 95 | 2 | EFO_0009706, MONDO_0005148 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 5.54e-04 | 11 | 95 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | Internal Carotid Artery Diseases | 5.54e-04 | 11 | 95 | 2 | C0750986 | |
| Disease | Arterial Diseases, Common Carotid | 5.54e-04 | 11 | 95 | 2 | C0750987 | |
| Disease | Carotid Atherosclerosis | 5.54e-04 | 11 | 95 | 2 | C0577631 | |
| Disease | External Carotid Artery Diseases | 5.54e-04 | 11 | 95 | 2 | C0600178 | |
| Disease | Carotid Artery Diseases | 5.54e-04 | 11 | 95 | 2 | C0007273 | |
| Disease | Schizophrenia | FOLH1 SPTBN2 LAMA1 NLGN1 GSTP1 ATXN2 ELAVL2 NLGN2 GNAO1 ATP2A2 | 5.58e-04 | 883 | 95 | 10 | C0036341 |
| Disease | inflammatory bowel disease | 6.30e-04 | 449 | 95 | 7 | EFO_0003767 | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 6.37e-04 | 52 | 95 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | asthma | 7.15e-04 | 751 | 95 | 9 | MONDO_0004979 | |
| Disease | Genetic chronic primary adrenal insufficiency | 7.82e-04 | 13 | 95 | 2 | Orphanet_101960 | |
| Disease | adverse effect, response to xenobiotic stimulus | 9.22e-04 | 59 | 95 | 3 | EFO_0009658, GO_0009410 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.08e-03 | 139 | 95 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | JT interval | 1.26e-03 | 248 | 95 | 5 | EFO_0007885 | |
| Disease | sinusitis (is_marker_for) | 1.52e-03 | 18 | 95 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 1.52e-03 | 18 | 95 | 2 | EFO_0006831, EFO_0006896 | |
| Disease | Age-related macular degeneration | 1.52e-03 | 18 | 95 | 2 | cv:C0242383 | |
| Disease | Autistic Disorder | 1.58e-03 | 261 | 95 | 5 | C0004352 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.69e-03 | 19 | 95 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | facial attractiveness measurement | 1.69e-03 | 19 | 95 | 2 | EFO_0009892 | |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.69e-03 | 19 | 95 | 2 | DOID:10003 (implicated_via_orthology) | |
| Disease | chronic obstructive pulmonary disease | 1.72e-03 | 688 | 95 | 8 | EFO_0000341 | |
| Disease | Colorectal Carcinoma | 1.95e-03 | 702 | 95 | 8 | C0009402 | |
| Disease | Disproportionate short stature | 1.99e-03 | 77 | 95 | 3 | C0878659 | |
| Disease | Autoimmune Hepatitis | 2.07e-03 | 21 | 95 | 2 | EFO_0005676 | |
| Disease | hypertrophic cardiomyopathy (is_implicated_in) | 2.27e-03 | 22 | 95 | 2 | DOID:11984 (is_implicated_in) | |
| Disease | frailty measurement | 2.48e-03 | 23 | 95 | 2 | EFO_0009885 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 2.69e-03 | 295 | 95 | 5 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | chronic hepatitis B virus infection | 2.70e-03 | 24 | 95 | 2 | EFO_0004239 | |
| Disease | Crohn's disease | 3.06e-03 | 441 | 95 | 6 | EFO_0000384 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GYYDSFSPGLEEDKK | 386 | Q8N944 | |
| SDPKKRGLYDQYGEE | 56 | O75953 | |
| FYPEEDGKTKGYIFL | 221 | P55884 | |
| DGKTKGYIFLEYASP | 226 | P55884 | |
| PKIVKEGEDDYYTDG | 121 | Q9P2B7 | |
| SGFDLFGEPYKVAEY | 46 | P51816 | |
| FGEPYKVAEYTNKGD | 51 | P51816 | |
| DTQYPYGEKQDEFKR | 61 | P30040 | |
| QGDYVKKPGDGDSFY | 771 | Q9P0K1 | |
| GQNSDSKEYYDPEGK | 296 | Q9NZW4 | |
| SLGYGFVNYIDPKDA | 91 | P26378 | |
| YIEVDGKKYPSSEDG | 1231 | Q8WUJ3 | |
| DYNEAKGVYEKVGEA | 426 | Q93084 | |
| YGIKKYGPFVADFAD | 111 | P24539 | |
| NKEQGYEAYEDLPKG | 306 | Q9NPF8 | |
| GVAYKDIFEGVYFPA | 551 | Q9UBL3 | |
| ETYQGDKVAAYGGKL | 1401 | P98160 | |
| KVFGDKDADGFYQGE | 1661 | O95153 | |
| IGDNTKKVYVYDPGA | 476 | Q0D2K2 | |
| PKSGGDYSYVKDIFG | 101 | Q9UHI5 | |
| GTLVGEDKYGNKYYE | 36 | Q9UI09 | |
| INGKKEAGIPEFYDY | 561 | P00751 | |
| PRGLFDEYGSKKSDY | 51 | Q58FF3 | |
| IDIFEDYIYGAGPKN | 4121 | Q9NZR2 | |
| YKDAIYVFGGDNGKT | 76 | Q8N653 | |
| KKFEEEGNPYYSSAR | 511 | Q9HCC0 | |
| DYEVKYHEKGAEGPS | 466 | P54760 | |
| YPGKTNDVGQKFYLD | 331 | P16233 | |
| NGGIYEGVFKTYSPK | 286 | Q99700 | |
| EYEKAQNPAYFEGKP | 396 | Q5JU85 | |
| GAKGVILYSDPADYF | 221 | Q04609 | |
| ADGTYQVEYTPFEKG | 1286 | O75369 | |
| YTNAKGESGLEEYPD | 1306 | Q92628 | |
| GIGDKVDAVYEKNGY | 426 | P45452 | |
| LFSYYGPQEGDKKGQ | 901 | Q92614 | |
| GYEEYNGNKPFFIKS | 656 | Q8TBB1 | |
| KAKGGGYESEDAYQN | 331 | Q13614 | |
| FKEVDGEGKPYYEVR | 201 | Q9NY33 | |
| SNFVDNLYGYPEGKD | 456 | Q8N2Q7 | |
| TYTAIEAPKGEFGVY | 396 | O75306 | |
| GFVYVKEPPVFKGDY | 4341 | Q96RW7 | |
| VFVKNPDGGSYAYAI | 436 | Q15646 | |
| GYGFKEEYEALPEGQ | 886 | O14522 | |
| TEEGSSKEDYYGNGK | 501 | Q16821 | |
| IGGYKGKDYSEAEAL | 556 | Q9UHC9 | |
| FEFSPYEVGLQKYGA | 531 | Q3MJ16 | |
| YEVGLQKYGAFIPSE | 536 | Q3MJ16 | |
| FVDNLYGYPEGKDTL | 436 | Q9NZ94 | |
| NFVDNLYGYPEGKDT | 401 | Q8NFZ3 | |
| DYNEAKGVYEKVGEA | 426 | P16615 | |
| SFAYGKEGYAEGKIP | 116 | Q9Y680 | |
| LKGVGDSFKKYPDYE | 521 | Q9Y4L1 | |
| DEAPKDIKGYYYNGD | 41 | O95352 | |
| LAGKAYYDGVAKIGE | 46 | Q9UHR4 | |
| VGSKINGYKAYDPEN | 486 | Q14574 | |
| KVEYYPVSGGKRQEF | 1416 | Q99715 | |
| TFGELKVPNDKYYGA | 56 | P07954 | |
| EEETSGYGFKPKYDG | 506 | Q9Y2H6 | |
| NYEAGKDDYVKALPG | 111 | P09211 | |
| GYGFVNYIDPKDAEK | 81 | Q12926 | |
| VFYNKDSEGALYPDG | 131 | Q6MZM0 | |
| KYNDGSPGREFYMDK | 606 | Q8WWI5 | |
| VFDNVGLSPDGYLYK | 1171 | Q5TBA9 | |
| SPDIKQQYGEGYIEK | 231 | Q9BPW9 | |
| SNFVDNLYGYPEGKD | 411 | Q8NFZ4 | |
| EEFKKIYGNFFPYGD | 46 | P61601 | |
| NFVDNLYGYPEGKDT | 401 | Q8N0W4 | |
| SPGKYTKQEGFLAYF | 286 | Q12889 | |
| VEFSPYEVGFLKYGA | 481 | Q86XP0 | |
| YVFPENGLVAYKDGK | 66 | O15305 | |
| GYDNYPGQEKTDDLK | 231 | Q92665 | |
| TGFGKENSTDYLYPE | 316 | P00749 | |
| FGGYVAKEKDIVYPG | 116 | O95807 | |
| PEKLYFVLDYVNGGE | 106 | Q9HBY8 | |
| KNKGSYVTYEPTEGE | 61 | Q0VAQ4 | |
| KYGIDPEDTKNYSGF | 1826 | Q9NTG1 | |
| QIYGFEGEVKAKYTA | 311 | P53041 | |
| DGSGYAALVKEGYKV | 2896 | P25391 | |
| FSGEDVKQYKPVVYS | 61 | P09471 | |
| AKYFPEYAEKIPGES | 51 | Q9NQR4 | |
| SEGNKLGEFLAYPYV | 391 | Q92966 | |
| QGYKGDNAVIPYETD | 1196 | Q9NRY4 | |
| KDGGPNVKYYEAADT | 6 | Q8TAQ2 | |
| YKDFGGDVAAYVAPT | 436 | O75153 | |
| TGEKPYEYQECGKAF | 251 | Q8IYI8 | |
| GSKPTEKGANEYAYA | 56 | Q8IWU4 | |
| STEDGGESPQKYIYF | 2671 | Q86UP3 | |
| EYYEIGPVSFEGLKA | 26 | Q96G30 | |
| GFYKDAKAASAGVPY | 2256 | O15020 | |
| EYGKVEFVFSYGPEK | 296 | Q9HBL0 | |
| KYTVFDAEGYVKPQS | 76 | O75425 | |
| NYVLPSDAGGSYKEE | 171 | O15060 | |
| GYTGPFKVETLKYHE | 506 | O60290 | |
| EYEKESPYGLSFNKG | 526 | Q07157 | |
| TGEKPYNCEEYGKAF | 536 | Q9H8G1 | |
| PSGKYNAVKLGKYED | 51 | B7Z8K6 | |
| FKGKYVTYDPDGNVE | 121 | Q504Y3 | |
| GYSVEEVYDLAKPFG | 916 | Q14966 | |
| FIYGKTGQPDKIYVE | 31 | Q6X784 | |
| GEKPYEHKEYGKAFG | 456 | Q96MR9 | |
| NAKPSEYEKIAFQYG | 216 | Q00872 |